Proactive Investors - Run By Investors For Investors

AdAlta manufacturing pulmonary fibrosis candidate in next quarter

AdAlta Limited (ASX: 1AD) CEO Sam Cobb sat down with Christine Corrado at the Biotech Showcase in San Francisco.

AdAlta is an Australian public biotechnology company focused on the development and commercialisation of its i-body technology platform that has generated a pipeline of i-bodies, with an initial focus on treating fibrotic diseases. 

 
View full 1AD profile View Profile

Adalta Ltd Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use